Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2005;330:601 (12 March), doi:10.1136/bmj.330.7491.601
| The first 150 words of the full text of this article appear below. |
EDITORThe front cover of the BMJ of 27 November declared that screening for aortic aneurysm does not reduce overall death rates. This headline misrepresents the conclusions of the study itself,1 let alone evidence from the UK multicentre aneurysm screening study of 68 000 men, which showed that screening halves aneurysm related deaths by reducing risk of rupture.2
|
The Australian trial studied 41 000 men aged 65-83, and the authors admit their target group was not suitable.1 Half the men over 75 invited for screening did not attend and accounted for two thirds of deaths from aneurysm. Among those aged 65-74, not one patient died of aneurysm disease in 8641 men attending screening, compared with 11 deaths in non-attendees and 13 deaths in controls. The authors concluded that the chief reasons for their overall result seemed to have been their failure to identify and exclude men who were unlikely
Peter Lamont, honorary secretary
Vascular Society at the Royal College of Surgeons, London WC2A 3PE Peter.Lamont@ubht.swest.nhs.uk
Read all Rapid Responses